Application of Lactose Co-Processed Excipients as an Alternative for Bridging Pharmaceutical Unit Operations: Manufacturing an Omeprazole Tablet Prototype via Direct Compression

Application of Lactose Co-Processed Excipients as an Alternative for Bridging Pharmaceutical Unit Operations: Manufacturing an Omeprazole Tablet Prototype via Direct Compression

Improving the manufacturability of drug formulations via direct compression has been of great interest for the pharmaceutical industry. Selecting excipients plays a vital role in obtaining a high-quality product without the wet granulation processing step. In particular, for diluents which are usual...

Full description

Saved in:
Bibliographic Details
Main Authors: Raymar Andreina Lara Garcia, Jesús Alberto Afonso Urich, Andreina Isabel Afonso Urich, Dalibor Jeremic, Johannes Khinast
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Scientia Pharmaceutica
Subjects:
co-process excipient
direct compression
drug delivery system(s)
formulation
oral drug delivery
solid dosage form(s)
Online Access:https://www.mdpi.com/2218-0532/93/2/24
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items